Advanced search

Instruments

	Name		Stock exchange	Average volume	Price	Type
	THE MEET KEVIN PRICING POWER ETF - USD	PP	Nyse	30,163	25.81 USD	ETF

News (286)

Transcript : DexCom, Inc., Q1 2024 Earnings Call, Apr 25, 2024	26/04
Dexcom Reports First Quarter 2024 Financial Results	26/04	BU
Dexcom Publishes Annual Sustainability Report	03/04	BU
Dexcom Showcases Leadership in AID and Power of Dexcom CGM in Type 2 Diabetes With New Data at ATTD	05/03	BU
Transcript : DexCom, Inc., Q4 2023 Earnings Call, Feb 08, 2024	09/02
Dexcom Reports Fourth Quarter and Fiscal Year 2023 Financial Results	09/02	BU
Transcript : DexCom, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 09:45 AM	08/01
Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2023 and Initial 2024 Outlook	08/01	BU
Dexcom to Present at 42nd Annual J.P. Morgan Healthcare Conference	19/12	BU
Dexcom Unveils Portrait Gallery to Portray Emotional Highs and Lows of Living With Diabetes on World Diabetes Day	14/11	BU
Transcript : DexCom, Inc., Q3 2023 Earnings Call, Oct 26, 2023	27/23/27
Dexcom Reports Third Quarter 2023 Financial Results, Raises 2023 Revenue and Margin Guidance, and Announces $500 Million Share Repurchase Program	27/23/27	BU
Dexcom Appoints Rimma Driscoll to Board of Directors	28/23/28	BU
Transcript : DexCom, Inc., Q2 2023 Earnings Call, Jul 27, 2023	28/23/28
Dexcom Reports Second Quarter 2023 Financial Results	28/23/28	BU
Transcript : Home Bancshares, Inc. (Conway, AR), Q2 2023 Earnings Call, Jul 20, 2023	20/23/20
Global Continuous Glucose Monitoring Pioneer Dexcom Reveals New Plans to Bring Sensing Technology to Millions More	24/23/24	BU
Dexcom Updates Long-Range Financial Targets	24/23/24	BU
Transcript : DexCom, Inc. - Analyst/Investor Day	24/23/24
Transcript : Tandem Diabetes Care, Inc. Presents at Jefferies 2023 Global Healthcare Conference, Jun-08-2023 01:30 PM	08/23/08
Transcript : DexCom, Inc., Q1 2023 Earnings Call, Apr 27, 2023	28/23/28
Dexcom Reports First Quarter 2023 Financial Results	28/23/28	BU
Dexcom Publishes Annual Sustainability Report	05/23/05	BU
Dexcom G7 Continuous Glucose Monitoring System Will Be Available to Medicare Beneficiaries at Launch	13/23/13	BU
Transcript : DexCom, Inc., Q4 2022 Earnings Call, Feb 09, 2023	10/23/10
Dexcom Reports Fourth Quarter and Fiscal Year 2022 Financial Results	10/23/10	BU
Dexcom and Nick Jonas Make Super Bowl Magic to Launch New Dexcom G7 Continuous Glucose Monitoring System	07/23/07	BU
Transcript : DexCom, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-09-2023 11:15 AM	10/23/10
Dexcom Appoints Teri Lawver as Chief Commercial Officer	09/23/09	BU
Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2022 and Initial 2023 Outlook	09/23/09	BU
Dexcom to Present at 41st Annual J.P. Morgan Healthcare Conference	03/23/03	BU
Republican Gallagher to lead new U.S. House China select committee	09/22/09	RE
DexCom Shares Up 4% After FDA Approval of Continuous Glucose Monitoring System	09/22/09	DJ
Dexcom G7 Receives FDA Clearance: The Most Accurate Continuous Glucose Monitoring System Cleared in the U.S.	08/22/08	BU
CORRECTING and REPLACING Gabelli Funds and Columbia Business School to Host 4th Annual Healthcare Symposium	15/22/15	BU
Piper Sandler : 2022 Heartland Summit Recap	15/22/15	PU
Dexcom Partners With Warriors and Nonprofits to Artfully Advocate for Access to Diabetes Care	01/22/01	BU
Transcript : DexCom, Inc., Q3 2022 Earnings Call, Oct 27, 2022	28/22/28
Dexcom Reports Third Quarter 2022 Financial Results	28/22/28	BU
Transcript : Perenti Global Limited - Shareholder/Analyst Call	14/22/14
Dexcom G7 Launches in the United Kingdom, Ireland, Germany, Austria and Hong Kong – Initiating Global Rollout of World’s Most Powerful Continuous Glucose Monitoring System	04/22/04	BU
Insulet Announces CE Mark Approval for Omnipod® 5 Automated Insulin Delivery System	20/22/20	BU
DexCom Promotes Jake Leach to Chief Operating Officer	01/22/01	BU
Transcript : DexCom, Inc. Presents at Canaccord Genuity 42nd Annual Growth Conference, Aug-10-2022 10:30 AM	10/22/10
Dexcom : Reports Second Quarter 2022 Financial Results - Form 8-K	29/22/29	PU

1234NextSee all

Companies (2)

INTERNATIONAL STAR, INC. 5 M $

International Star, Inc. operates, through its wholly owned subsidiary, Budding Equity Inc., a royalty-based business that owns intellectual property contracts with movie studios, which provide for the licensing of that intellectual property (IP) to third ...

TAPINATOR, INC. 2 M $

Tapinator, Inc. develops and publishes games for mobile platforms. The Companyâs portfolio includes over 300 titles that have over 500 million mobile downloads, including games such as Video Poker Classic and Crypto Trillionaire. It publishes two types ...

Insiders

Kevin Sayer

Mr. Kevin R. Sayer, CPA, is a Chairman, President & Chief Executive Officer at DexCom, Inc. Mr. Sayer was previously employed as a Chief Financial Officer & Secretary by Biosensors International Group Ltd., a Chief Financial Officer & Executive Vice President by Specialty Laboratories, Inc., an Independent Director by Akesis Pharmaceuticals, Inc., a Vice President & General Manager by Medtronic MiniMed, Inc., and a Chief Financial Officer by MiniMed, Inc. He received his undergraduate degree from Brigham Young University and a graduate degree from Brigham Young University.

Thomas Sayer has worked as a General Counsel for Pacifica Cos.
LLC since 1998.

Clive Alexander Sayer

No results for this search